268600 — Cellivery Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Cellivery Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19,650 | -17,248 | -28,069 | -75,159 | -34,036 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 7,572 | 2,926 | 7,583 | 14,126 | 13,207 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -501 | -2,813 | -3,719 | -544 | 7,088 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11,581 | -16,097 | -22,744 | -56,381 | -8,791 |
| Capital Expenditures | -630 | -1,208 | -4,590 | -17,649 | -64.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 9,496 | -697 | -3,959 | 13,134 | 3,951 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 8,867 | -1,905 | -8,549 | -4,514 | 3,887 |
| Financing Cash Flow Items | -0.438 | -516 | -1,486 | -53.9 | -2.98 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,976 | 45,442 | 71,941 | 6,117 | -8,216 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 262 | 27,433 | 40,647 | -54,748 | -13,119 |